癌症患者的mHealth应用程序中的教育和症状报告:混合方法开发和验证研究
Carolina Muñoz Olivar1,2, Miguel Pineiro2,3, Juan Sebastián Gómez Quintero4
1PhD in Health Sciences, Faculty of Medicine, Antonio Nariño University, Bogotá, 111511, Colombia.
JMIR human factors
|April 28, 2025
概括
开发了一个新的移动健康应用程序CONTIGO,以改善接受化疗的癌症患者的沟通. 虽然功能强大,但它需要在用户参与和定制方面进行改进,以获得更好的患者护理.
科学领域:
- 数字健康数字健康
- 在瘤学瘤学.
- 移动健康应用 移动健康应用
背景情况:
- 癌症治疗,特别是化疗,在管理副作用方面存在挑战.
- 癌症患者和医疗保健提供者之间的有效沟通对于早期检测和治疗副作用的管理至关重要.
- 移动健康 (mHealth) 应用程序提供了一种潜在的解决方案,可以弥合沟通差距并改善患者的治疗结果.
研究的目的:
- 设计一个以癌症为重点的移动健康应用程序 (CONTIGO),集成化学疗法患者的教育内容和实时症状报告.
- 通过使用移动应用评分表 (MARS) 验证和评估CONTIGO应用的质量.
- 加强医疗保健沟通,减少住院再接收,并优化癌症患者的症状管理.
主要方法:
- 在开发和验证mHealth应用程序时,采用了混合方法方法.
- CONTIGO应用程序是由多学科的医疗保健专业人员和软件工程师团队使用敏捷方法设计的.
- 13名评估人员使用MARS评估了应用程序质量,并进行了技术性能分析.
主要成果:
- CONTIGO应用程序表现出强大的功能 (4.35/5) 和出色的视觉稳定性.
- 整体MARS评分为3.75/5,表明质量一致,尽管用户参与度得分较低 (3.31/5).
- 评估人员确定了需要改进的领域,包括定制,登陆和导航,同时承认了应用程序的潜在好处.
结论:
- 在功能,可用性和信息质量方面,CONTIGO应用程序在瘤护理方面表现有前途.
- 需要进一步开发以提高用户的互动性和参与度.
- 未来的代将纳入患者反,以改进应用程序并改善整体癌症护理体验.
相关概念视频
01:21Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
02:43Mouse Models of Cancer Study
5.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K